Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02713529
Recruitment Status : Completed
First Posted : March 18, 2016
Last Update Posted : October 23, 2019
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2, 2019
Actual Study Completion Date : May 17, 2019
Certification/Extension First Submitted : October 15, 2019